Immunotherapy for myeloid leukemias: current status and future directions


Myeloid leukemias, although a heterogeneous group of hematopoietic stem cell neoplasms, are arguably among the most suited for active specific immunotherapy. Nevertheless, clinical development of myeloid leukemia vaccine lagged behind similar approaches in other solid and hematological malignancies. The recent identification of apparently specific leukemia… (More)
DOI: 10.1038/leu.2008.148

2 Figures and Tables


  • Presentations referencing similar topics